Stay updated with breaking news from Henry Killworth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Seven scientists at UCL will take on some of the toughest obstacles in cancer, after being selected to play leading roles in the latest global Cancer Grand Challenges.
15.05.2022 - Robot-assisted surgery used to perform bladder cancer removal enables patients to recover far more quickly and spend significantly (20 per cent) less time in hospital, concludes a first-of-its kind clinical trial led by scientists at UCL and the University of Sheffield.
Published in Scientific Reports, the study builds on the team’s previous work*, which showed daily three-minute exposure to longwave deep red light
11 February 2021 One-third (35%) of people who took a new drug for treating obesity lost more than one-fifth (≥20%) of their total body weight, according to a major global study involving UCL researchers. The findings from the large-scale international trial, published in the New England Journal for Medicine, are being hailed as a “game changer” for improving the health of people with obesity and could play a major part in helping the UK to reduce the impact of diseases, such as COVID-19. The drug, semaglutide, works by hijacking the...
DGAP-News: Apogenix AG / Key word(s): Study 22.12.2020 / 10:00 COVID-19: targeted treatment trial launched in Vienna (Vienna/Heidelberg/Cologne/London, 22 December 2020) A phase II clinical trial of a treatment for COVID-19 patients is currently starting at the Medical University of Vienna as a sub-study of the Austrian CoronaVirus Adaptive Clinical Trial (ACOVACT). The trial was initiated as an academia-industry collaboration (investigator Initiated trial) between Apogenix AG, a biotech company based in Heidelberg, and their scientific consultant Henning Walczak and his teams at the Univer...